Abstract | OBJECTIVES: This study was designed to determine the enhancement profile of a necrosis-specific contrast agent (gadophrin III) in comparison to a standard extracellular agent on T1-weighted magnetic resonance (MR) images in acute and chronic myocardial infarctions (MIs). BACKGROUND: Contrast-enhanced MR imaging demonstrated the ability to accurately quantify infarct size; however, some controversies persist about which contrast medium is best suited. METHODS: Fifteen rabbits underwent thoracotomy and permanent occlusion of a branch of the left coronary artery. Two animals died before imaging, eight were examined 48 h after occlusion and five animals were imaged six weeks following induction of infarction. All animals received 50 micromol/kg of gadophrin-3 24 h before the MR examination. Continuous short-axis views were collected using an inversion recovery turbo fast low angle shot sequence. Imaging was repeated 5 to 10 min following additional injection of 100 micromol/kg of Magnevist. The area of hyperenhancement demarcated following gadophrin-3 injection was compared with the region of hyperenhancement seen on gadophrin-3 plus Magnevist enhanced image using triphenyltetrazolium chloride (TTC) staining as the standard of reference. RESULTS: In acute MI the mean difference in size of hyperenhancement seen on the two different in vivo MR scans was -1.8 +/- 6.0 mm(2) (p > 0.05). Both measurements showed excellent agreement with TTC staining. Chronic MIs showed no enhancement with gadophrin-3, whereas application of Magnevist resulted in hyperenhancement. CONCLUSIONS; Standard extracellular contrast agents do not overestimate the size of acute MI. The combination of gadophrin-3 and Magnevist can distinguish acute and chronic myocardial injury because chronic MIs do not enhance with gadophrin-3.
|
Authors | Jörg Barkhausen, Wolfgang Ebert, Jörg F Debatin, Hanns-Joachim Weinmann |
Journal | Journal of the American College of Cardiology
(J Am Coll Cardiol)
Vol. 39
Issue 8
Pg. 1392-8
(Apr 17 2002)
ISSN: 0735-1097 [Print] United States |
PMID | 11955861
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Contrast Media
- Tetrazolium Salts
- triphenyltetrazolium
- Gadolinium
- Gadolinium DTPA
|
Topics |
- Animals
- Contrast Media
(pharmacology)
- Disease Models, Animal
- Female
- Gadolinium
(pharmacology)
- Gadolinium DTPA
(pharmacology)
- Image Enhancement
- Injections, Intravenous
- Magnetic Resonance Imaging
- Male
- Myocardial Infarction
(diagnosis, pathology)
- Rabbits
- Staining and Labeling
- Tetrazolium Salts
|